文献速递胸部肿瘤

新型ROS1免疫组化克隆SP384在非小细胞肺癌ROS1重排检测中的评估:ROSING研究

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study.
PubMed 文献 · J Thorac Oncol · 2019-07-23

ROSING研究在多中心43例ROS1 FISH阳性与193例阴性NSCLC样本中评估新型ROS1免疫组化抗体SP384,并与D4D6克隆及FISH比较。SP384以H-score≥150或≥70%肿瘤细胞染色强度≥2+为最佳截断值,敏感性和特异性分别为93%和100%。SP384是所提检测流程中优秀的分析选项。

要点

  • SP384最佳截断值:H-score≥150或≥70%肿瘤细胞强度≥2+,敏感性93%、特异性100%。
  • D4D6克隆H-score≥100时敏感性91%、特异性100%。
  • SP384检测正常肺ROS1表达更频繁(p<0.0001)。

核心结论

  • 新型SP384 ROS1免疫组化克隆表现出极好的敏感性且不牺牲特异性,是所提检测流程中优秀的分析选项。

研究设计与样本

  • 多中心系列研究纳入43例ROS1 FISH阳性和193例ROS1 FISH阴性的NSCLC样本。
  • 所有样本用D4D6和SP384两种抗体筛查,不同判读标准与断裂分离FISH比较。
  • FISH阳性样本进一步行下一代测序(Oncomine Dx Target Test Panel)。

主要发现

  • SP384克隆以H-score≥150或≥70%肿瘤细胞染色强度≥2+为最佳截断值,敏感性和特异性分别为93%和100%。
  • D4D6克隆以H-score≥100为截断值,敏感性和特异性分别为91%和100%。
  • SP384克隆检测正常肺ROS1表达更频繁(p<0.0001)。
  • EZR-ROS1变异与膜性染色及FISH孤立绿信号模式相关(p=0.001和p=0.017)。

关键数值与推荐

  • SP384最佳截断值:H-score≥150或≥70%肿瘤细胞染色强度≥2+(敏感性93%,特异性100%)。
  • D4D6最佳截断值:H-score≥100(敏感性91%,特异性100%)。

临床怎么用

  • 所提检测流程支持ROS1免疫组化作为筛查试验,所有阳性结果需经FISH或分子检测确认。
  • SP384可作为该检测流程中ROS1免疫组化筛查的分析选项之一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The ROS1 gene rearrangement has become an important biomarker in NSCLC. The College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology testing guidelines support the use of ROS1 immunohistochemistry (IHC) as a screening test, followed by confirmation with fluorescence in situ hybridization (FISH) or a molecular test in all positive results. We have evaluated a novel anti-ROS1 IHC antibody (SP384) in a large multicenter series to obtain real-world data. METHODS: A total of 43 ROS1 FISH-positive and 193 ROS1 FISH-negative NSCLC samples were studied. All specimens were screened by using two antibodies (clone D4D6 from Cell Signaling Technology and clone SP384 from Ventana Medical Systems), and the different interpretation criteria were compared with break-apart FISH (Vysis). FISH-positive samples were also analyzed with next-generation sequencing (Oncomine Dx Target Test Panel, Thermo Fisher Scientific). RESULTS: An H-score of 150 or higher or the presence of at least 70% of tumor cells with an intensity of staining of 2+ or higher by the SP384 clone was the optimal cutoff value (both with 93% sensitivity and 100% specificity). The D4D6 clone showed similar results, with an H-score of at least 100 (91% sensitivity and 100% specificity). ROS1 expression in normal lung was more frequent with use of the SP384 clone (p < 0.0001). The ezrin gene (EZR)-ROS1 variant was associated with membranous staining and an isolated green signal FISH pattern (p = 0.001 and p = 0.017, respectively). CONCLUSIONS: The new SP384 ROS1 IHC clone showed excellent sensitivity without compromising specificity, so it is another excellent analytical option for the proposed testing algorithm.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Conde E, Hernandez S, Martinez R, et al. Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study. J Thorac Oncol. 2019. PMID: 31349061. doi:10.1016/j.jtho.2019.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。